Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome

被引:95
作者
Van Den Eede, Filip
Moorkens, Greta
Van Houdenhove, Boudewijn
Cosyns, Paul
Claes, Stephan J.
机构
[1] Univ Antwerp Hosp, Dept Psychiat, BE-2650 Edegem, Belgium
[2] Univ Antwerp Hosp, Dept Internal Med, BE-2650 Edegem, Belgium
[3] Univ Antwerp, Collaborat Antwerp Psychiat Res Inst, B-2020 Antwerp, Belgium
[4] Univ Antwerp VIB, Dept Mol Genet, VIB8, B-2610 Antwerp, Belgium
[5] Univ Hosp Gasthuisberg, Dept Psychiat, B-3000 Louvain, Belgium
关键词
challenge test; cortisol; corticotropin-releasing factor; fatigue; neuroendocrinology; stress;
D O I
10.1159/000104468
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There is evidence for a hypofunction of the hypothalamic-pituitary-adrenal (HPA) axis in a proportion of the patients with chronic fatigue syndrome (CFS), despite the negative studies and methodological difficulties. In this review, we focus on challenge studies and on the role of the HPA axis in the pathogenesis of CFS. Mild hypocortisolism, blunted adrenocorticotropin response to stressors and enhanced negative feedback sensitivity to glucocorticoids are the main findings. Several underlying mechanisms have been proposed. Currently, it is a matter of debate whether these disturbances have a primary role in the pathogenesis of CFS. However, even if the HPA axis dysfunctions are secondary to other factors, they are probably a relevant factor in symptom propagation in CFS. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:112 / 120
页数:9
相关论文
共 83 条
[1]   Chronic fatigue syndrome: A review [J].
Afari, N ;
Buchwald, D .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (02) :221-236
[2]   Abnormalities in response to vasopressin infusion in chronic fatigue syndrome [J].
Altemus, M ;
Dale, JK ;
Michelson, D ;
Demitrack, MA ;
Gold, PW ;
Straus, SE .
PSYCHONEUROENDOCRINOLOGY, 2001, 26 (02) :175-188
[3]   Chronic fatigue syndrome: a form of Addison's disease [J].
Baschetti, R .
JOURNAL OF INTERNAL MEDICINE, 2000, 247 (06) :737-739
[4]   NEUROENDOCRINE RESPONSES TO D-FENFLURAMINE AND INSULIN-INDUCED HYPOGLYCEMIA IN CHRONIC FATIGUE SYNDROME [J].
BEARN, J ;
ALLAIN, T ;
COSKERAN, P ;
MUNRO, N ;
BUTLER, J ;
MCGREGOR, A ;
WESSELY, S .
BIOLOGICAL PSYCHIATRY, 1995, 37 (04) :245-252
[5]   Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: A randomized, placebo-contriolled, double-blind, crossover study [J].
Blockmans, D ;
Persoons, P ;
Van Houdenhove, B ;
Lejeune, M ;
Bobbaers, H .
AMERICAN JOURNAL OF MEDICINE, 2003, 114 (09) :736-741
[6]   CORTICOTROPIN-RELEASING FACTOR - ACTIONS ON THE SYMPATHETIC NERVOUS-SYSTEM AND METABOLISM [J].
BROWN, MR ;
FISHER, LA ;
SPIESS, J ;
RIVIER, C ;
RIVIER, J ;
VALE, W .
ENDOCRINOLOGY, 1982, 111 (03) :928-931
[7]   Predictors of outcome in a fatigued population in primary care following a randomized controlled trial [J].
Chalder, T ;
Godfrey, E ;
Ridsdale, L ;
King, M ;
Wessely, S .
PSYCHOLOGICAL MEDICINE, 2003, 33 (02) :283-287
[8]   Corticotropin-releasing hormone (CRH) as a regulator of waking [J].
Chang, FC ;
Opp, MR .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2001, 25 (05) :445-453
[9]   THE CONCEPTS OF STRESS AND STRESS SYSTEM DISORDERS - OVERVIEW OF PHYSICAL AND BEHAVIORAL HOMEOSTASIS [J].
CHROUSOS, GP ;
GOLD, PW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (09) :1244-1252
[10]   The corticotropin-releasing hormone binding protein is associated with major depression in a population from northern Sweden [J].
Claes, S ;
Villafuerte, S ;
Forsgren, T ;
Sluijs, S ;
Del-Favero, J ;
Adolfsson, R ;
Van Broeckhoven, C .
BIOLOGICAL PSYCHIATRY, 2003, 54 (09) :867-872